Our results indicate that both Pg-AgNPs elicited an antiproliferative activity, however, Pg-AgNPs_S2 was more effective in decreasing breast and lung cancer cell viability than Pg-AgNPs_S1. The gene discussed is JUP; the disease is lung cancer.